Nureca Limited has filed a disclosure under Regulation 10(6) of SEBI Takeover Regulations dated January 27, 2026, reporting an increase in promoter group shareholding following completion of its share buyback program. The promoter group shareholding rose from 64.97% to 68.09% due to extinguishment of shares purchased during the buyback. The buyback program opened on December 18, 2025, closed on December 24, 2025, with shares subsequently extinguished on January 7, 2026.
The change in shareholding percentage resulted from reduction in total share capital rather than fresh acquisition by promoters. Total shares decreased from 1,00,00,175 to 95,41,920, representing a reduction of 4,58,255 shares. The promoter group maintained their absolute holding of 64,97,176 shares while their percentage increased by 3.12 percentage points. Public shareholding correspondingly decreased from 35.03% to 31.91%.
The promoter group consists of five entities with Saurabh Goyal holding the largest stake of 32,17,214 shares (33.72%), increased from 32.17% pre-buyback. Payal Goyal holds 20,59,928 shares (21.59%), up from 20.60%. Aryan Goyal's stake increased to 12.15% from 11.59% with 11,59,185 shares. Nectar Biopharma Private Limited holds 60,842 shares (0.64%) while Smita Goyal holds 7 shares.
The disclosure was made under Regulation 10(6) of SEBI Takeover Regulations with the promoter group claiming exemption under Regulation 10(4)(c). This exemption applies when shareholding percentage increase results from buyback rather than fresh share acquisition. The company confirmed no prior intimation under Regulation 10(5) was required as the transaction qualified for the specified exemption. Nureca Limited is listed on BSE Limited (scrip code: 532649) and National Stock Exchange (scrip: NECLIFE).
